A Study of BL-B01D1 in Patients With Recurrent Glioblastoma

NCT06598787 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

20

Enrollment

INDUSTRY

Sponsor class

Conditions

Recurrent Glioblastoma

Interventions

DRUG: BL-B01D1 for Injection

Sponsor

Sichuan Baili Pharmaceutical Co., Ltd.

Collaborators

[object Object]